Trademarkia Logo

Canada

C$
Trademark Search in Canada
OpenDEL

View On IC.GC.CA

OpenDEL
SEARCHED

on 6 Nov 2024

Last Applicant/ Owned by

HitGen Inc.

Floor 3, Building 1, No. 88, Keyuan South Road,High-tech Zone, ChengduSichuan

CN

Serial Number

2270489 filed on 19th Apr 2023

OpenDEL

Trademark usage description

chemical preparations for scientific purposes, namely, dna encoded compound library raw material reagents; chemical substances for analyzing dna encod Read More

Classification Information

Class [001]
Chemical preparations for scientific purposes, namely, dna encoded compound library raw material reagents; chemical substances for analyzing dna encoded compound libraries in laboratories; chemical reagents for use in genetic research; dna encoded compound library enzyme reagents for scientific purposes; buffer solutions for use in analytical chemistry; biochemical catalysts.

Classification kind code

12

Class [005]
Drugs for medical purposes, namely, pharmaceutical preparations for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; biological preparations for medical purposes for the treatment of tumors, cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, epstein-barr (EB) viruses, hormonal diseases, allergic, immune disorder, torch infections and immunoglobulin diseases; antibiotics; medicines for human purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; medicines made of chinese traditional medicinal herbs for controlling blood pressure; medicines made of chinese traditional medicinal herbs for controlling cholesterol; medicines made of chinese traditional medicinal herbs for the treatment of allergies; medicines made of chinese traditional medicinal herbs for the treatment of colds and flu; medicines made of chinese traditional medicinal herbs for treating ocular disorders; biochemical drugs for the treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, inflammatory disorders, dermatological conditions, oncological diseases, blood diseases, connective tissue disorders, ophthalmic diseases, and gastroenterological disorders; chemical preparations for pharmaceutical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; allergy tablets; antibiotic tablets; vitamin tablets; effervescent vitamin tablets.

Classification kind code

12

Class [042]
Research and development of new products for others; scientific laboratory services, namely, laboratory research in the field of pharmaceuticals and nutraceuticals; scientific laboratory services, namely, laboratory research in the field of chemistry; chemical research; consultancy in the field of chemistry; chemical analysis; bacteriological research; biological therapeutic research services.

Classification kind code

12

Mark Details

Serial Number

2270489

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 22
on 6th Nov 2024		Search Recorded
Submitted for opposition 20
on 6th Nov 2024		Examiner's First Report
Submitted for opposition 223
on 6th Nov 2024		Total Provisional Refusal
Submitted for opposition 256
on 20th May 2024		Notification of Possible Opposition Sent
Submitted for opposition 257
on 20th Jul 2023		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 19th Jul 2023		Created
Submitted for opposition 31
on 19th Jul 2023		Formalized
Submitted for opposition 30
on 19th Apr 2023		Filed
Submitted for opposition 228
on 19th Apr 2023		International Registration